Navigation Links
Frontiers news briefs: 27 June
Date:6/28/2013

l division during mitosis. While some tumors maintain a stably aneuploid genome, many cancer cells persistently mis-segregate their chromosomes during mitosis, a phenomenon known as chromosomal instability (CIN). CIN is thought to drive the genomic re-shuffling that enables cells to acquire new phenotypes such as drug resistance and is intimately associated with loss of mitotic fidelity. Emerging data show that CIN and de-regulated cell signaling pathways are closely interrelated suggesting the roles that signaling pathways play in the accuracy of mitosis may be underappreciated. These results imply that the induction of CIN can no longer be thought of as a separate event from the cancer-associated driver mutations found in cell signaling pathways. In the context of tumorigenesis this may turn out to be a double-edged sword that combines de-regulated cell cycle progression with the disruption of mitosis to generate the highly complex genomic rearrangements typical of solid tumors. These results change the way we think about how to intervene therapeutically in cancer patients and provide insights on the molecular targets that may contribute significantly to improve patient prognosis.

Researcher contact:

Prof. Duane A. Compton
Department of Biochemistry
Geisel School of Medicine at Dartmouth, USA
Email: duane.a.compton@dartmouth.edu

URL: http://www.frontiersin.org/Molecular_and_Cellular_Oncology/10.3389/fonc.2013.00164/abstract


'/>"/>

Contact: Gozde Zorlu
gozde.zorlu@frontiersin.org
Frontiers
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Finding new research frontiers in a single cell
2. Frontiers announces launch of new open-access journal, Frontiers in Public Health
3. Frontiers launches new open-access journal in Bioengineering and Biotechnology
4. Frontiers news briefs: May 23
5. Frontiers launches new open-access journal in physics
6. Frontiers news briefs May 30
7. Frontiers news briefs: June 6
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:3/19/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet ... on Washington DC,s Fox 5 News ... Next Great Thing", host Laura Evans calls the ... really big breakthrough in mobile payment.,  Award-winning ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
... is the liquid elixir that nurtures the growth of billions ... ample supply of water for farming and agriculture often means ... world, however, suffer from the opposite - the growing scarcity ... drought and desertification to climate change and climate variability, pollution, ...
... DC Scientists at the Lombardi Comprehensive Cancer Center at ... million grant to tease apart in the most comprehensive ... in breast cells in cancer development and treatment. This protein ... breast cancer and how she will fare during her treatment. ...
... 22nd, 2010-Riparian areas, ecosystems caught between the land ... temporal variability. Effectively managing and protecting riparian areas ... concepts. Fortunately, scientists are investigating new approaches in ... One of those approaches is photography. By taking ...
Cached Biology News:More water for life 2More water for life 3Lombardi receives $7.5 million grant for Breast Cancer Center for Cancer Systems Biology 2Lombardi receives $7.5 million grant for Breast Cancer Center for Cancer Systems Biology 3Learning about riparian areas from photographs 2
(Date:4/1/2015)... CITY and LONDON , April ... research reports and solutions, MarketResearch.com is pleased to highlight a ... a year of market growth and opportunity for the stem ... company or cord blood bank, competing in the stem cell ... predict industry trends, and act on market changes before the ...
(Date:4/1/2015)... Parsippany, NJ (PRWEB) April 01, 2015 ... joined BioNJ, a vibrant life sciences industry association that ... over 400 members. , Jonathan Parker, AJO’s Vice ... Annual Gala Dinner in February, an event that attracted ... evening’s highlights, Don Wright, a 73 year old cancer ...
(Date:4/1/2015)... 1, 2015 Immunocore Limited ... biological drugs to treat cancer, viral infections and ... appointment of Christina Coughlin as Chief ... providing medical and regulatory leadership to the pre-clinical ... Dr. Coughlin has extensive experience in oncology drug ...
(Date:3/31/2015)... BOCA RATON, Fla. , March 31, 2015 /PRNewswire/ ... biotherapeutic products, is pleased to announce the addition of ... Ward Drive, Suite 205 Conway, Arkansas ... opened its doors for business on March 26 th ... plasma collection centers to eighteen. "This ...
Breaking Biology Technology:MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4HR Consulting Firm, A.J. O'Connor Associates Joins BioNJ – The Vibrant 400 Member Strong Life Sciences Industry Association - and Attends its Annual Dinner 2Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 2Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 3Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 4Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Conway, Arkansas 2
... , ... --,China Yongxin Pharmaceuticals, Inc. (OTC Bulletin Board: CYXN; ,China ... of pharmaceuticals in Northeastern China, today announced it has,completed ... List. , The Chinese government ...
... , NOVATO, Calif., Nov. 30 BioMarin Pharmaceutical Inc. ... and Drug Administration (FDA) has granted orphan drug designation ... disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has ... Also, in October 2009, the Committee for Medicinal Products ...
... , SEATTLE, ... MTA: CTIC) announced today that its new class of ... potency and activity compared to currently available platinum-based compounds ... cancer cell lines. The results were presented in ...
Cached Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood CD8+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Biology Products: